Shuttle Pharmaceuticals Files 8-K on Equity Sales
Ticker: SHPH · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, 8-k
TL;DR
Shuttle Pharma filed an 8-K on June 25th, reporting a material agreement for unregistered equity sales on June 20th.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on June 20, 2025, related to unregistered sales of equity securities. The company, incorporated in Delaware with its principal executive offices in Gaithersburg, MD, filed this 8-K report on June 25, 2025.
Why It Matters
This filing indicates potential new equity financing or sales, which could impact the company's capital structure and shareholder dilution.
Risk Assessment
Risk Level: medium — Unregistered equity sales can sometimes signal financial distress or a need for capital, potentially leading to dilution.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- June 20, 2025 (date) — Date of earliest event reported
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What specific material definitive agreement was entered into by Shuttle Pharmaceuticals?
The filing indicates a material definitive agreement related to unregistered sales of equity securities, but the specific details of the agreement are not provided in this excerpt.
When did the event triggering this 8-K filing occur?
The earliest event reported occurred on June 20, 2025.
What is the company's state of incorporation and principal executive office location?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
What is the SEC file number for Shuttle Pharmaceuticals Holdings, Inc.?
The SEC file number is 001-41488.
What is the SIC code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).